- Home
- NN vs ZYME Comparison
NN vs ZYME Comparison
Compare NN & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NN | ZYME |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | 103 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NN | ZYME |
|---|---|---|
| Price | $22.57 | $24.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $25.00 | ★ $38.90 |
| AVG Volume (30 Days) | ★ 3.0M | 542.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $105,965,000.00 |
| Revenue This Year | N/A | $183.10 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 38.87 |
| 52 Week Low | $10.84 | $11.02 |
| 52 Week High | $24.19 | $29.75 |
Technical Indicators
Market Signals| Indicator | NN | ZYME |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 40.64 |
| Support Level | $13.79 | $22.50 |
| Resistance Level | $24.19 | $27.54 |
| Average True Range (ATR) | 1.23 | 1.22 |
| MACD | 0.27 | -0.33 |
| Stochastic Oscillator | 94.71 | 18.35 |
Price Performance
Historical ComparisonAbout NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.